Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Medical Management / Watchful Waiting
Treatment for Non-rheumatic degenerative mitral valve disease
Typical Dosage: Varies by medication (e.g., Lisinopril 5-40mg daily, Metoprolol 25-200mg daily)
Effectiveness
40%
Safety Score
80%
Clinical Trials
500
Participants
200K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
80
DangerousModerateSafe
Treatment Details
Dosage Range
Varies by medication (e.g., Lisinopril 5-40mg daily, Metoprolol 25-200mg daily)
Time to Effect
Days to weeks for symptom management
Treatment Duration
Lifetime
Evidence Quality
HIGHConfidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$1,000
Monitoring:$1,500
Side Effect Mgmt:$200
Total Annual:$2,700
Outcome-Based Costs
Cost per Responder
$4,153.85
Medical Management / Watchful Waiting Outcomes
for Non-rheumatic degenerative mitral valve disease
Efficacy Outcomes
Overall Effectiveness
+40%
Response Rate
+65%
Common Side Effects
Fatigue (from beta-blockers)
+15%
Cough (from ACE inhibitors)
+10%
Dizziness/Hypotension
+7%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov